NEUROCRINE BIOSCIENCES INC (NBIX)
US64125C1099 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 249.70M | 154.50M | 89.60M | 407.30M | 37.00M | |||
| Depreciation Amortization | 21.30M | 15.60M | 10.90M | 8.60M | 7.50M | |||
| Income Taxes - Deferred | -56.70M | 19.10M | 4.30M | -310.70M | N/A | |||
| Change In Working Capital | 28.20M | -67.40M | 16.70M | -37.90M | 200.00K | |||
| Interest Paid | 3.80M | 6.60M | 8.60M | 11.60M | 11.60M | |||
| Taxes Paid | 51.50M | 14.40M | 5.10M | 15.30M | 500.00K | |||
| Other non cash items | 147.40M | 217.60M | 135.00M | 161.20M | 107.30M | |||
| OPERATING CASH FLOW | 389.90M | 339.40M | 256.50M | 228.50M | 152.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -28.30M | -16.50M | -23.40M | -10.90M | -14.70M | |||
| Other Investing Activity | -438.80M | -160.60M | -106.80M | 15.00M | -196.30M | |||
| INVESTING CASH FLOW | -467.10M | -177.10M | -130.20M | 4.10M | -211.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -279.00M | -100.00K | -186.90M | 0.00 | |||
| Stock Issued/Repurchased | 65.30M | 44.70M | 27.50M | 29.10M | 27.30M | |||
| FINANCING CASH FLOW | 65.30M | -234.30M | 27.40M | -157.80M | 27.30M | |||
| Exchange Rate Effect | 300.00K | -1.30M | N/A | N/A | N/A | |||
| CHANGE IN CASH | -11.60M | -73.30M | 153.70M | 74.80M | -31.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 389.90M | 339.40M | 256.50M | 228.50M | 152.10M | |||
| Capital Expenditure | -28.30M | -16.50M | -23.40M | -10.90M | -14.70M | |||
| FREE CASH FLOW | 361.60M | 322.90M | 233.10M | 217.60M | 137.40M | |||
All data in USD